HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice.

Abstract
Impaired wound healing is a problem for immobilized patients, diabetics, and the elderly. Thymosin beta 4 has previously been found to promote dermal and corneal repair in normal rats. Here we report that thymosin beta 4 was also active in accelerating wound repair in full-thickness dermal wounds in both db/db diabetic and aged mice. We found that thymosin beta 4 in either phosphate-buffered saline or a hydrogel formulation is active in promoting dermal wound repair in normal rats. In diabetic mice, where healing is delayed, we found that wound contracture and collagen deposition were significantly increased in the mice treated with thymosin beta 4 in either phosphate buffered saline solution or a hydrogel formulation. No difference was observed in keratinocyte migration, with all of the diabetic animals showing almost complete coverage of the wound at 8 days. Wound healing in 26-month-old (aged) animals was significantly delayed. Thymosin beta 4 accelerated wound healing in these aged mice, with increases in keratinocyte migration, wound contracture, and collagen deposition. The hydrogel formulation generally showed similar wound healing activity with thymosin beta 4 in PBS. The actin-binding domain of thymosin beta 4 duplicated in a seven-amino acid synthetic peptide, LKKTETQ, was able to promote repair in the aged animals comparable to that observed with the parent molecule. These studies show that thymosin beta 4 is active for wound repair in models of impaired healing and may have efficacy in chronic wounds in humans.
AuthorsDeborah Philp, Mahnaz Badamchian, Brooke Scheremeta, Mychi Nguyen, Allan L Goldstein, Hynda K Kleinman
JournalWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society (Wound Repair Regen) 2003 Jan-Feb Vol. 11 Issue 1 Pg. 19-24 ISSN: 1067-1927 [Print] United States
PMID12581423 (Publication Type: Journal Article)
Chemical References
  • Microfilament Proteins
  • thymosin beta(4)
  • Thymosin
Topics
  • Age Factors
  • Animals
  • Disease Models, Animal
  • Female
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred NOD
  • Microfilament Proteins (therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Skin (drug effects, injuries, physiopathology)
  • Thymosin (therapeutic use)
  • Wound Healing (drug effects, physiology)
  • Wounds, Penetrating (drug therapy, pathology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: